Abiopharma

Aurora Spine Corporation Announces First Quarter FY26 Financial Results

Report of the subsidiary Ayalon: Examination of the possibility of issuing deferred capital notes Tier 1 - update regarding an institutional tender

Amber International Holding Limited Reports First Quarter 2026 Unaudited Financial Results

The companys financial results for the First Quarter 2026 were published abroad.

Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD

Veeva Quality Cloud Advances Manufacturing Operations for Kindeva

Ingredion announces strategic partnership with Sanstar Limited expanding access to pharma and food ingredient markets in India

908 Devices Inc. - 908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference

Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference

Ambow Education Holding Ltd. (NYSE American: AMBO) Launches HybriU™ Partner Portal With 150-Plus Sales Partner Applicants, Opening an Uncapped Commission Program for Its AI-Powered Phygital Platform